Jonathan Trent on Trabectedin for Soft Tissue Sarcoma

Jonathan Trent, MD, PhD, associate director for clinical research, director of the Sarcoma Medical Research Program at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, discusses the approval of trabectedin (Yondelis) to treat patients with soft tissue sarcoma.

• Categoria